unknown
Stage
1
Investors
About
Cardurion Pharmaceuticals develops novel therapeutics targeting cardiovascular diseases by focusing on PDE9 and CaMKII inhibition to address heart failure and arrhythmias.
Explore Cardurion Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.